ZEN Stock Overview
Engages in the research and development of graphene and related nanomaterials in Canada. More details
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Zentek Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$1.71 |
52 Week High | CA$2.12 |
52 Week Low | CA$0.75 |
Beta | 0.76 |
11 Month Change | 48.70% |
3 Month Change | 33.59% |
1 Year Change | 11.76% |
33 Year Change | -73.89% |
5 Year Change | 356.00% |
Change since IPO | 180.33% |
Recent News & Updates
Recent updates
Does Zentek (CVE:ZEN) Have A Healthy Balance Sheet?
Jul 09Is ZEN Graphene Solutions (CVE:ZEN) In A Good Position To Deliver On Growth Plans?
Aug 31We're Keeping An Eye On ZEN Graphene Solutions' (CVE:ZEN) Cash Burn Rate
Mar 11We Think ZEN Graphene Solutions (CVE:ZEN) Needs To Drive Business Growth Carefully
Nov 26Shareholder Returns
ZEN | CA Medical Equipment | CA Market | |
---|---|---|---|
7D | 28.6% | 4.5% | 0.7% |
1Y | 11.8% | 6.1% | 21.7% |
Return vs Industry: ZEN exceeded the Canadian Medical Equipment industry which returned 3.7% over the past year.
Return vs Market: ZEN underperformed the Canadian Market which returned 21.4% over the past year.
Price Volatility
ZEN volatility | |
---|---|
ZEN Average Weekly Movement | 15.7% |
Medical Equipment Industry Average Movement | 13.4% |
Market Average Movement | 8.3% |
10% most volatile stocks in CA Market | 17.6% |
10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: ZEN's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: ZEN's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2008 | 24 | Greg Fenton | www.zentek.com |
Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing graphene oxide synthesis and graphene synthesis.
Zentek Ltd. Fundamentals Summary
ZEN fundamental statistics | |
---|---|
Market cap | CA$177.95m |
Earnings (TTM) | -CA$10.74m |
Revenue (TTM) | CA$39.36k |
4,522x
P/S Ratio-16.6x
P/E RatioIs ZEN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ZEN income statement (TTM) | |
---|---|
Revenue | CA$39.36k |
Cost of Revenue | CA$461.93k |
Gross Profit | -CA$422.58k |
Other Expenses | CA$10.32m |
Earnings | -CA$10.74m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.10 |
Gross Margin | -1,073.73% |
Net Profit Margin | -27,291.69% |
Debt/Equity Ratio | 2.8% |
How did ZEN perform over the long term?
See historical performance and comparison